Western CDMOs say near-term stewardship of the pharmaceutical source chain is probably going to require them to repurpose creation lines to manufacture medicines and raw materials important to fighting the new coronavirus.six The company designs to generate 70% of its greatest-quantity products as a result of steady manufacturing in 8 several year